Venous thromboembolism incidence in postoperative breast cancer patients
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Citação
CLINICS, v.78, article ID 100229, 6p, 2023
Resumo
Background: Venous Thromboembolism (VTE) is an important cause of morbidity in cancer patients. Breast cancer patients undergoing surgical treatment are at an increased risk of VTE. The aim of this study was to determine the frequency of VTE in patients who underwent surgery for the treatment of breast cancer and to identify the related risk factors. Methods: A historical cohort of patients at the Sao Paulo State Cancer Institute (ICESP) underwent surgery for breast cancer. The inclusion criteria covered patients with invasive breast cancer or ductal carcinoma in situ who had breast surgery anytime from January 2016 to December 2018. Results: Of the 1672 patients included in the study, 15 had a confirmed diagnosis of VTE (0.9%), and 3 of these had deep vein thrombosis (0.2%), and 12, had pulmonary thromboembolism (0.7%). Clinical and tumoral characteristics did not differ between the groups. The incidence of VTE was higher in patients who had undergone skin-sparing mastectomy or nipple-sparing mastectomy (p = 0.032). Immediate reconstruction, particularly with abdominal-based flaps (4.7%), increased VTE events (p = 0.033). Median surgical time was higher in patients with VTE episodes (p = 0.027), and total hospital length of stay increased in days (6 days vs. 2 days, p = 0.001). Neoadjuvant chemotherapy and postoperative prophylaxis with Low Molecular Weight Heparin (LMWH) were associated with lower VTE rates (0.2% vs. 1.2%, p = 0.048 and 0.7% vs. 2.7%, p = 0.039; respectively) in these patients. Conclusions: The incidence of VTE events in breast cancer patients who underwent surgery was 0.9%. Immediate reconstruction (especially with abdominal-based flaps), skin-sparing/nipple-sparing mastectomies, and longer surgeries were associated with increased risk. The LMWH postoperative prophylaxis reduced this risk.
Palavras-chave
Breast neoplasms, Venous thromboembolism, Pulmonary embolism
Referências
- Andtbacka RHI, 2006, ANN SURG, V243, P96, DOI 10.1097/01.sla.0000193832.40178.0a
- Blom JW, 2006, J THROMB HAEMOST, V4, P529, DOI 10.1111/j.1538-7836.2006.01804.x
- Cameron IC, 2001, BREAST, V10, P535, DOI 10.1054/brst.2000.0252
- Castaldi M, 2021, PLAST SURG-CHIR PLAS, V29, P160, DOI 10.1177/2292550320967397
- de Oliveira VM, 2008, REV ASSOC MED BRAS, V54, P6, DOI 10.1590/S0104-42302008000100008
- Enajat M, 2013, PLAST RECONSTR SURG, V131, P1213, DOI 10.1097/PRS.0b013e31828bd35e
- Grosse SD, 2016, THROMB RES, V137, P3, DOI 10.1016/j.thromres.2015.11.033
- Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208
- Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
- Kim EK, 2009, PLAST RECONSTR SURG, V123, P9, DOI 10.1097/PRS.0b013e3181904be7
- Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004
- Londero AP, 2022, CANCERS, V14, DOI 10.3390/cancers14040988
- Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852
- Malta M, 2010, REV SAUDE PUBL, V44, P559, DOI 10.1590/S0034-89102010000300021
- Momeni A, 2018, ANN PLAS SURG, V80, P188, DOI 10.1097/SAP.0000000000001249
- Ohashi Y, 2020, JPN J CLIN ONCOL, V50, P1246, DOI 10.1093/jjco/hyaa112
- Olsson EH, 2005, SCAND J PLAST RECONS, V39, P33, DOI 10.1080/02844310410021730
- RICKLES FR, 1983, BLOOD, V62, P14
- Rogers MAM, 2012, CIRCULATION, V125, P2092, DOI 10.1161/CIRCULATIONAHA.111.084467
- Spear SL, 2005, PLAST RECONSTR SURG, V115, P84, DOI 10.1097/01.PRS.0000145723.05286.F7
- Tran BH, 2013, BREAST, V22, P444, DOI 10.1016/j.breast.2013.04.018
- Walker AJ, 2016, BLOOD, V127, P849, DOI 10.1182/blood-2015-01-625582